Limitations of Cox Proportional Hazards Analysis in Mortality Prediction of Patients with Acute Coronary Syndrome
暂无分享,去创建一个
Elżbieta Chełmecka | Aleksander Owczarek | Jerzy Chudek | J. Chudek | K. Klimek | A. Owczarek | Magdalena Babińska | Małgorzata Janik | Katarzyna Klimek | M. Babińska | E. Chełmecka | M. Janik
[1] N. Ata,et al. Cox Regression Models with Nonproportional Hazards Applied to Lung Cancer Survival Data , 2007 .
[2] F. Van de Werf,et al. Underestimated and under-recognized: the late consequences of acute coronary syndrome (GRACE UK-Belgian Study). , 2010, European heart journal.
[3] P. Grambsch,et al. Proportional hazards tests and diagnostics based on weighted residuals , 1994 .
[4] W. Markiewicz,et al. Prognostic importance of hyponatremia in acute ST-elevation myocardial infarction. , 2004, The American journal of medicine.
[5] A. Larsson,et al. Cystatin C- and creatinine-based estimates of renal function and their value for risk prediction in patients with acute coronary syndrome: results from the PLATelet Inhibition and Patient Outcomes (PLATO) study. , 2013, Clinical chemistry.
[6] Sooriyarachchi,et al. Use of Schoenfeld’s global test to test the proportional hazards assumption in the Cox proportional hazards model: an application to a clinical study , 2009 .
[7] K. Filion,et al. Anemia and mortality in acute coronary syndromes: a systematic review and meta-analysis. , 2013, American heart journal.
[8] Gaëtan MacGrogan,et al. Variables with time-varying effects and the Cox model: Some statistical concepts illustrated with a prognostic factor study in breast cancer , 2010, BMC medical research methodology.
[9] C. Murray,et al. Global and regional mortality from ischaemic heart disease and stroke attributable to higher-than-optimum blood glucose concentration: comparative risk assessment , 2006, The Lancet.
[10] L. Hansson,et al. Cystatin C: A Novel Predictor of Outcome in Suspected or Confirmed Non–ST-Elevation Acute Coronary Syndrome , 2004, Circulation.
[11] W. Markiewicz,et al. Prognostic importance of hyponatremia in acute ST-elevation myocardial infarction , 2004 .
[12] L. Wallentin,et al. Admission N-terminal pro-brain natriuretic peptide and its interaction with admission troponin T and ST segment resolution for early risk stratification in ST elevation myocardial infarction , 2005, Heart.
[13] D. Zahger,et al. Soroka acute myocardial infarction (SAMI) score predicting 10-year mortality following acute myocardial infarction. , 2013, International journal of cardiology.
[14] D. Aronson,et al. Hyponatraemia predicts the acute (type 1) cardio‐renal syndrome , 2014, European journal of heart failure.
[15] Luke Keele,et al. Proportionally Difficult: Testing for Nonproportional Hazards in Cox Models , 2010, Political Analysis.
[16] C. Tetta,et al. C-Reactive Protein and Interleukin-6 Levels Are Related to Renal Function in Predialytic Chronic Renal Failure , 2002, Nephron.
[17] Hyun Woong Park,et al. Carotid plaque is associated with increased cardiac mortality in patients with coronary artery disease. , 2013, International Journal of Cardiology.
[18] G. Bellomo,et al. Inflammation, infection and cardiovascular events in chronic hemodialysis patients: a prospective study. , 2003, Journal of nephrology.
[19] P. Avignon,et al. Causes of Death , 1884, Nature.
[20] P. Sasieni,et al. A note on scaled Schoenfeld residuals for the proportional hazards model , 2001 .
[21] G. Kurland,et al. Radioactive Iodine Treatment of Angina Pectoris and Congestive Heart Failure , 1957, Circulation.
[22] M. Zahid,et al. Effect of hyponatremia (<135 mEq/L) on outcome in patients with non-ST-elevation acute coronary syndrome. , 2007, The American journal of cardiology.
[23] David A. Schoenfeld,et al. Partial residuals for the proportional hazards regression model , 1982 .
[24] Paul W Armstrong,et al. Declining in-hospital mortality and increasing heart failure incidence in elderly patients with first myocardial infarction. , 2009, Journal of the American College of Cardiology.
[25] J. Núñez,et al. Early determination of homocysteine levels in acute coronary syndromes, is it an independent prognostic factor? , 2005, International journal of cardiology.
[26] M. Bozbay,et al. Prognostic value of total bilirubin in patients with ST-segment elevation acute myocardial infarction undergoing primary coronary intervention. , 2013, The American journal of cardiology.
[27] C. Schmid,et al. A new equation to estimate glomerular filtration rate. , 2009, Annals of internal medicine.
[28] A. Walker,et al. Anemia as a predictor of cardiovascular events in patients with elevated serum creatinine. , 2006, Journal of the American Society of Nephrology : JASN.
[29] Finn Gustafsson,et al. 2010 Focused Update of ESC Guidelines on Device Therapy in Heart Failure , 2011 .
[30] D. Zahger,et al. A new risk score predicting 1- and 5-year mortality following acute myocardial infarction Soroka Acute Myocardial Infarction (SAMI) Project. , 2012, International journal of cardiology.
[31] G. Gensini,et al. Usefulness of hyponatremia in the acute phase of ST-elevation myocardial infarction as a marker of severity. , 2012, The American journal of cardiology.
[32] P. Sasieni,et al. Miscellanea. A note on scaled Schoenfeld residuals for the proportional hazards model , 2001 .
[33] J. De Sutter,et al. Plasma N-terminal pro-brain natriuretic peptide concentration predicts coronary events in men at work: a report from the BELSTRESS study. , 2005, European heart journal.
[34] M. Grabowski,et al. Comparison of the seven-year predictive value of six risk scores in acute coronary syndrome patients: GRACE, TIMI STEMI, TIMI NSTEMI, SIMPLE, ZWOLLE and BANACH. , 2014, Kardiologia polska.